Celestia and Injective Lift Altcoins Alongside Bitcoin
Celestia and Injective benefited from stronger risk appetite, while the Altcoin Season index climbed and Bitcoin stayed stuck around $82,100.
Key Takeaways
- Bitcoin held around $82,100 overnight on Thursday and recovered from a brief drop to about $81,600.
- Celestia rose 16%, Injective 7.7%, and LayerZero 7.3%, while the Altcoin Season index climbed from 50 to 60.
- Injective posted $289.7 million in 24-hour volume, 128% more than a day earlier, while the Fed kept the market on edge.
Bitcoin moved little overnight on Thursday and traded around $82,100 (€73,300), after briefly slipping earlier to about $81,600 (€72,800). That kept Bitcoin well above Thursday’s short dip below $80,000 (€71,400), the first time in a month that level was broken.
Altcoins Pick Up Speed
The broader crypto market showed more strength in the meantime. Ether rose 0.5% to $2,462.52 (€2,200) and the CoinDesk 80 gained 0.46%, while the Bitcoin-heavy CoinDesk 5 was basically flat. Celestia jumped 16%, Injective rose 7.7%, and LayerZero gained 7.3%. That left four of the five members of the CoinDesk 100 higher and pushed CoinMarketCap’s Altcoin Season index up from 50 to 60.
That move fits a market where investors are temporarily showing more interest in altcoins than in Bitcoin alone. Celestia drew extra attention because the project uses a modular data availability layer, where consensus and execution are separated. That makes it easier to verify data without downloading entire blocks.
Fed Keeps Market on Edge
The picture outside crypto was calm too. Asian stocks bounced back after Thursday’s selloff, with the Kospi up 2.05% and the Nikkei up 1.39%. S&P 500 futures were barely changed after the index snapped a three-day losing streak.
Federal Reserve Chair Kevin Warsh gave no clear signal in Bangkok about the interest rate decision later this month. According to the CME Fedwatch tool, the odds of an October rate hike fell to about 15% from around 30% earlier. U.S. yields mostly stayed steady.
Injective Stays in Focus
Injective remained one of the strongest names of the day. Along with the price jump, trading activity pointed to more attention on the token, with 24-hour volume of $289.7 million (€258 million), 128% higher than a day earlier. The network is focused on DeFi and has long attracted traders active in derivatives and other on-chain markets.
For European crypto followers, the key point is that rotation into altcoins often shows up faster in tokens with a clear use case or an active trading base. That makes the move in Celestia and Injective interesting as a sign of broader risk appetite in the crypto market, without meaning it automatically turns into a lasting trend. The recent rise in altcoin trading also shows how quickly the market can flip when risk appetite improves.
